Fundraising Fox

Lucy Therapeutics

Cambridge, US · Founded 2017 · Delaware corporation · 3 employees on LinkedIn

Founders & leadership

Lucy Therapeutics was founded in 2017 by Amy Ripka.

AR
Amy RipkaFounder
AD
Ann DeWittNamed on SEC filing
JR
John RippleNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$28.6M disclosed across 3 rounds · 2019–2023

$10.6MraisedMay 2024 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Rachel ShaDirector
  • Robert Michael PooleDirector
  • Amy RipkaExecutive Officer, Director
  • John RippleDirector
Offering amount
$10.6M
Amount sold
$10.6M
First sale
Dec 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15MraisedJan 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John RippleDirector
  • Amy RipkaExecutive Officer, Director
  • Karoly NikolichDirector
  • Ann DeWittDirector
Offering amount
$20M
Amount sold
$15M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3MraisedJul 2020 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Amy RipkaExecutive Officer, Director
  • Ann DeWittDirector
  • John RippleDirector
Offering amount
$4.5M
Amount sold
$3M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Lucy Therapeutics?
Lucy Therapeutics was founded by Amy Ripka in 2017.
How much funding has Lucy Therapeutics raised?
Lucy Therapeutics has disclosed $28.6M raised across 3 rounds.
Where is Lucy Therapeutics headquartered?
Lucy Therapeutics is headquartered in Cambridge, US.